The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic value of CD56, ASCL1, and other biomarkers in small cell bladder cancer (SCBC).
 
Vadim S. Koshkin
No Relationships to Disclose
 
Jordan Reynolds
No Relationships to Disclose
 
Paul Elson
No Relationships to Disclose
 
Jesse McKenney
No Relationships to Disclose
 
Kumiko Isse
Employment - Abbvie/Stemcentrx
Stock and Other Ownership Interests - Abbvie/Stemcentrx
 
Laura R. Saunders
Employment - Abbvie/Stemcentrx
Stock and Other Ownership Interests - Abbvie/Stemcentrx
Patents, Royalties, Other Intellectual Property - Abbvie/Stemcentrx
 
Ming Hu
No Relationships to Disclose
 
Andrew J. Stephenson
Speakers' Bureau - Genomic Health
 
Amr Farouk Fergany
No Relationships to Disclose
 
Byron Lee
No Relationships to Disclose
 
Brian I. Rini
Consulting or Advisory Role - Corvus Pharmaceuticals; Merck; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Jorge A. Garcia
Consulting or Advisory Role - Bayer; Eisai; Exelixis; Genentech/Roche; Medivation; Pfizer; Sanofi
Speakers' Bureau - Bayer; Genentech/Roche; Medivation/Astellas; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Lilly (Inst); Orion (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bayer; Eisai; Exelixis; Genentech/Roche; Medivation/Astellas; Pfizer; Sanofi
 
Omar Y. Mian
No Relationships to Disclose
 
Petros Grivas
Consulting or Advisory Role - AstraZeneca; Bayer; Biocept; Bristol-Myers Squibb; Clovis Oncology; Dendreon; EMD Serono; Exelixis; Genentech; Merck
Speakers' Bureau - Bristol-Myers Squibb; Genentech
Research Funding - AstraZeneca (Inst); Bayer (Inst); Genentech/Roche (Inst); Merck (Inst); Mirati Therapeutics (Inst); Oncogenex (Inst); Pfizer (Inst)